Abstract
J.D. We have so far discussed some of the variables in filtration techniques reproduced in this diagram. We have tried to assess the relative importance and contribution of these different factors and how we can interpret the results produced by combinations of these factors. In this session we want to apply ourselves to the question: are the results, irrespective of the exact technique of filtration used, clinically relevant? I mean by that, are the results of any filtration test useful in the prediction, management, determining the prognosis of the disease or the development of new forms of therapy? What we have in the filtration test is a kind of black box into which we pour the blood and out of which comes a number. You can approach such a phenomenon in two ways; so far we have been approaching it from the basic science point of view — what is actually being measured inside that box? But we can also look at the number we get out of the box and see whether it is clinically relevant. I would suggest that these two paths should be followed simultaneously rather than consecutively. They are interrelated and if we can acurately define the clinical states which produce abnormal results new light may be thrown on what we are actually measuring, and vice versa.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References to Fig. 7.31
F. De Clerck, et al. Arch. int. Pharmacodyn., 1977, 230: 321–323.
F. De Clerck, et al. In Hemorheology and diseases; Stoltz J.F., Drouin P. Eds: 669–676; Doin Editeurs, 1980.
J. De Cree, et al. Angiology, 1979, 30: 505–515.
C. K. Scott, et al. Angiology, 1980, 31: 320–330.
T. Di Perri, et al. Proc. Roy. Soc. Med., 1978, 70 (Suppl. 8): 25–28.
M. Guerrini, et al. 2nd European Conference on Clinical Haemorheology, 30 Sept. — 2 Oct., London 1981, abstract n° 226.
A.M. Ehrly, et al. 2nd European Conference on Clinical Haemorheology, 30 Sept. — 2 Oct., London 1981, abstract n° 185.
T. Di Perri, et al. Br. J. Clin. Pharmac., 1978, 5: 255–260.
T. Di Perri, et al. Angiology, 1981, 32: 257–265.
S. Ono, et al. Thromb. Haemost., 1981, 46, abstract n° 0544.
M. Stäubli, et al. Atherosclerosis, 1982, 41: 167–170.
R. Bonniot, et al. Archives Médicales de l’Ouest, 1980, 12: 577–594.
M. Gueguen, et al. Le Praticien, 1981, 376: 57–64.
R. Roncucci, et al. Arzneim. Forsch./Drug Res., 1979, 29 (I), Nr. 4.
P. Chatelain, et al. Biochemical Pharmacology, 30: 313–317.
C. Le Devehat, et al. Angéiologie XXXII, 1980, 4: 177–181.
J.A. Dormandy, et al. Angiology, 1981, 32: 714–716.
M. Materazzi, et al. 2nd European Conference on Clinical Haemorheology, 30 Sept. — 2 Oct., London 1981, Abstract n° 230.
L. Savi, et al. La Vie Médicale, 1979, 60: 285–287.
J. Hudomel, et al. Ophtal. Res., 1977, 9: 25–30.
R.L. Henry, et al. Diabetes, 1981, 30 (Suppl. 1), 83 A, abstract n° 330.
M. Harrison, et al. 2nd European Conference on Clinical Haemorheology, 30 Sept. — 2 Oct., London 1981, abstract n° 167.
A.M. Ehrly. IRCS Medical Science, 1975, 3: 465.
U. Werner. Med. Welt., 1975, 26: 2098–2099.
C. Vigneron, et al. Médecine Actuelle, 1977, 4: 200–204.
M. Guillot, et al. Third Int. Congress of Biorheology, La Jolla, 28 Aug. — 1 Sept. 1978, abstract p. 150.
J.A. Dormandy, et al. Current Medical Research and Opinion, 1981, 7: 520–522.
Y. Isogai, et al. Current Medical Research and Opinion, 1981, 7: 352–358.
H. Leonhardt, et al. Naunyn-Schmiedeberg’s Arch. Pharmacol, 1977, 299: 197–200.
H. Leonhardt, et al. La Ricerca Clin. Lab., 1978, 8: 65–71.
H.G. Grigoleit, et al. VASA, 1977, 6: 274–278.
D. Seiffge, et al. Klin. Wochenschr., 1981, 59: 1271–1272.
D. Seiffge. Scand. J. Clin. Lab. Invest., 1981, 41 (Suppl. 156): 251–253.
D. Seiffge, et al. La Ricerca Clin. Lab., 1981, 11 (Suppl. 1): 117–123.
J.A. Sirs, et al. Biorheology, 1978, 15: 53–54.
P. Martin, et al. Current Medical Research and Opinion, 1980, 6: 512–522.
C. Le Devehat, et al. Scand. J. Clin. Lab. Invest., 1981, 41 (Suppl. 156): 301–303.
S. Gaillard, et al. Annales Médicales de Nancy et de l’Est. 1979; XVIII: 1099–1102.
R. Schubotz, et al. Curr. Med. Res. Opin., 1977, 4: 609–617.
B. Angelkort, et al. Curr. Med. Res. Opin., 1979, 6: 255–258.
R. Johnsson, et al. Scand. J. Clin. Lab. Invest., 1981, 41 (Suppl. 156): 297–300.
H. Nagata, et al. 10th Europ. Conf. Microcirculation. Biblthca anat., N° 18, pp. 125–128 (Karger, Basel 1979).
K.I. Zinzadse, et al. Pharmatherapeutica, 1978, 2 (Suppl. 1): 118–122.
H.G. Grigoleit, et al. Pharmatherapeutica, 1976, 1: 241–247.
D. Harwart. Current Medical Research and Opinion, 1979, 6: 73–84.
D. Seiffge. spivn In ‘7ème Réunion du Groupe Français de Filtration Erythrocytaire, ! 982, p. 21.
M.A. Perego, et al. Angéiologie XXXIV, 1982: 33–41.
B. Störnier, et al. Current Medical Research and Opinion, 1977, 4: 588–595.
H. Heidrich, et al. IRCS Medical Science, 1976, 4: 368.
H. Hess, et al. Fortschr. Med., 1973, 91: 743–748.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Dormandy, J. (1983). Clinical relevance of filtration tests. In: Dormandy, J. (eds) Red Cell Deformability and Filterability. Developments in Hematology and Immunology, vol 6. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6726-7_11
Download citation
DOI: https://doi.org/10.1007/978-94-009-6726-7_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-6728-1
Online ISBN: 978-94-009-6726-7
eBook Packages: Springer Book Archive